Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Gear Up for UiPath (PATH) Q3 Earnings: Wall Street Estimates for Key Metrics


Wall Street analysts forecast that UiPath (PATH) will report quarterly earnings of $0.14 per share in its upcoming release, pointing to a year-over-year increase of 27.3%. It is anticipated that revenues will amount to $392.62 million, exhibiting an increase of 10.7% compared to the year-ago quarter.

The current level reflects no revision in the consensus EPS estimate for the quarter over the past 30 days. This demonstrates how the analysts covering the stock have collectively reappraised their initial projections over this period.

Prior to a company's earnings release, it is of utmost importance to factor in any revisions made to the earnings projections. These revisions serve as a critical gauge for predicting potential investor behaviors with respect to the stock. Empirical studies consistently reveal a strong link between trends in earnings estimate revisions and the short-term price performance of a stock.

While investors typically rely on consensus earnings and revenue estimates to gauge how the business may have fared during the quarter, examining analysts' projections for some of the company's key metrics often helps gain a deeper insight.

That said, let's delve into the average estimates of some UiPath metrics that Wall Street analysts commonly model and monitor.

The collective assessment of analysts points to an estimated 'Revenue- Licenses' of $140.47 million. The estimate suggests a change of +2.4% year over year.

Based on the collective assessment of analysts, 'Revenue- Professional Services and other' should arrive at $10.89 million. The estimate points to a change of +3.2% from the year-ago quarter.

The consensus among analysts is that 'Revenue- Subscription services' will reach $241.54 million. The estimate suggests a change of +16.7% year over year.

The combined assessment of analysts suggests that 'ARR' will likely reach $1.77 billion. Compared to the present estimate, the company reported $1.61 billion in the same quarter last year.

It is projected by analysts that the 'Net New ARR' will reach $50.57 million. Compared to the current estimate, the company reported $56.00 million in the same quarter of the previous year.

View all Key Company Metrics for UiPath here>>>

Over the past month, shares of UiPath have returned -16.2% versus the Zacks S&P 500 composite's +0.4% change. Currently, PATH carries a Zacks Rank #3 (Hold), suggesting that its performance may align with the overall market in the near future. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> .

Quantum Computing Stocks Set To Soar

Artificial intelligence has already reshaped the investment landscape, and its convergence with quantum computing could lead to the most significant wealth-building opportunities of our time.

Today, you have a chance to position your portfolio at the forefront of this technological revolution. In our urgent special report, Beyond AI: The Quantum Leap in Computing Power, you'll discover the little-known stocks we believe will win the quantum computing race and deliver massive gains to early investors.

Access the Report Free Now >>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report


 
UiPath, Inc. (PATH): Free Stock Analysis Report

This article originally published on Zacks Investment Research (zacks.com).

Zacks Investment Research


Source Zacks-com

At Zacks, we are dedicated to independent investment research, helping investors succeed through tools like our Zacks Rank stock-rating system, which has averaged +23.89% annual returns since 1988. Founded on the discovery that earnings estimate revisions drive stock prices, we offer purely mathematical, unbiased ratings, along with additional innovations like the Price Response Indicator, Earnings ESP, and specialized rankings for mutual funds and ETFs.
...
Legal notice

Comments